Clinical applications of serum markers for lung cancer

This publication has 118 references indexed in Scilit:

• CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation
  European Journal Of Cancer, 1994
• Clinical usefulness of serum assays of neuron-specific enolase, carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer
  European Journal Of Cancer, 1993
• In vitro effect of suramin on lung tumour cells
  European Journal Of Cancer, 1993
• Soluble Interleukin 2 Receptor in Acute Viral Hepatitis and Chronic Liver Disease
  Hepatology, 1989
• SCC-Antigen: ein sensitiver und spezifischer Tumormarker für Plattenepithelkarzinome?
  Deutsche Medizinische Wochenschrift (1946), 1988
• Topographic localization of the heparin-binding domain of the neural cell adhesion molecule N-CAM.
  The Journal of cell biology, 1986
• Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms
  New England Journal of Medicine, 1986
• The role of serum tumour markers to aid the selection of lung cancer patients for surgery and the assessment of prognosis
  European Journal of Cancer and Clinical Oncology, 1985
• Chromogranin A: Immunohistology reveals its universal occurrence in normal polypeptide hormone producing endocrine glands
  Life Sciences, 1983
• Evidence for a new form of enolase in rat brain
  Biochemical and Biophysical Research Communications, 1975